![Kathy Harrison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathy Harrison
Direktor/Vorstandsmitglied bei
Havah Therapeutics Pty Ltd.
Profil
Kathy Harrison is currently a Director at Havah Therapeutics Pty Ltd. since 2024.
Formerly, Ms. Harrison was Chief Operating Officer at Dimerix Ltd. in 2018.
Education includes graduation from The University of Manchester.
Aktive Positionen von Kathy Harrison
| Unternehmen | Position | Beginn |
|---|---|---|
Havah Therapeutics Pty Ltd.
 Havah Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures therapies with reduced side effects and early prevention & treatment of breast cancers | Direktor/Vorstandsmitglied | 01.06.2024 |
Ehemalige bekannte Positionen von Kathy Harrison
| Unternehmen | Position | Ende |
|---|---|---|
| DIMERIX LIMITED | Vorstandsvorsitzender | 27.08.2018 |
Ausbildung von Kathy Harrison
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimerix Ltd.
 Dimerix Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of biopharmaceutical drugs | Health Technology |
Havah Therapeutics Pty Ltd.
Havah Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures therapies with reduced side effects and early prevention & treatment of breast cancers | Commercial Services |
